| Mr Michael Wilusz, | |
|
1 Myrtle St, Adams, MA 01220-1726 | |
| (413) 743-5702 | |
| (413) 743-0710 |
| Full Name | Mr Michael Wilusz |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1 Myrtle St, Adams, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770882532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15798 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Wilusz, 1 Myrtle St, Adams, MA 01220-1726 Ph: (413) 743-5702 | Mr Michael Wilusz, 1 Myrtle St, Adams, MA 01220-1726 Ph: (413) 743-5702 |
News Archive
A Finnish research group has been the first in the world to publish an article in which BNCT treatment has had an excellent response in a patient with head and neck cancer for whom there was no other treatment available.
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced the U.S. launch of its award-winning CASCADIA Interbody Systems, featuring Lamellar 3D Titanium Technology, during the 31st North American Spine Society (NASS) Annual Meeting, Oct. 26-29, 2016, in Boston at Booth #1615.
BioRestorative Therapies, Inc., a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement with Rohto Pharmaceutical Company, Ltd. Under the Agreement, BRT has been engaged to provide stem cell research and development services.
Women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline, suggests a study from researchers at the Johns Hopkins Bloomberg School of Public Health.
More than 230,000 men will be diagnosed with prostate cancer this year in the United States, but determining their course of treatment remains a source of considerable debate. A new study by researchers from Uppsala University Hospital, Sweden, Harvard School of Public Health and colleagues—which draws from one of the few randomized trials conducted to directly address this issue—finds a substantial long-term reduction in mortality for men with localized cancer who undergo a radical prostatectomy.
› Verified 1 days ago
Thomas E Viale Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 Columbia St, Adams, MA 01220 Phone: 413-743-4659 Fax: 413-743-2608 | |
Lillian Kate Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 Columbia St, Adams, MA 01220 Phone: 413-743-4659 | |
Christine Celia Hessler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 Columbia St, Adams, MA 01220 Phone: 413-743-4659 | |
Mr. Richard L Guettler, RPH., CDM, MTM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 Columbia St, Adams, MA 01220 Phone: 413-743-4659 Fax: 413-743-2608 |